Transcriptome and proteome profiling of canine mammary tumors: dog as a genetic model for unraveling mammary cancer molucular signatures

[1]  D. Argyle,et al.  Dual targeting of EGFR and ERBB2 pathways produces a synergistic effect on cancer cell proliferation and migration in vitro , 2017, Veterinary and comparative oncology.

[2]  A. R. Fernandes,et al.  Immortalization and characterization of a new canine mammary tumour cell line FR37‐CMT , 2017, Veterinary and comparative oncology.

[3]  C. Benazzi,et al.  Immunohistochemical Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Hyperplasia, Neoplasia and Supporting Stroma. , 2016, Journal of comparative pathology.

[4]  F. Queiroga,et al.  Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors. , 2016, Veterinary immunology and immunopathology.

[5]  F. Gärtner,et al.  VEGFR-2 expression in malignant tumours of the canine mammary gland: a prospective survival study. , 2016, Veterinary and comparative oncology.

[6]  S. Rogatto,et al.  Evaluation of vascular endothelial growth factor gene and protein expression in canine metastatic mammary carcinomas , 2016, Microscopy research and technique.

[7]  H. Sakai,et al.  Canine tumor development and crude incidence of tumors by breed based on domestic dogs in Gifu prefecture , 2016, The Journal of veterinary medical science.

[8]  K. Lindblad-Toh,et al.  Genome-Wide Analysis Identifies Germ-Line Risk Factors Associated with Canine Mammary Tumours , 2016, PLoS genetics.

[9]  R. Harman,et al.  A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species , 2016, Journal of Mammary Gland Biology and Neoplasia.

[10]  P. Patra,et al.  Using Gold Nanoparticles as Delivery Vehicles for Targeted Delivery of Chemotherapy Drug Fludarabine Phosphate to Treat Hematological Cancers. , 2016, Journal of nanoscience and nanotechnology.

[11]  L. Peña,et al.  Profile of Steroid Receptors and Increased Aromatase Immunoexpression in Canine Inflammatory Mammary Cancer as a Potential Therapeutic Target. , 2016, Reproduction in domestic animals = Zuchthygiene.

[12]  G. Erten,et al.  Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27 , 2016, The Journal of veterinary medical science.

[13]  P. DeInnocentes,et al.  Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models , 2015, Journal of cellular biochemistry.

[14]  F. Queiroga,et al.  Serum and Tissue Steroid Hormone Levels in Canine Mammary Tumours: Clinical and Prognostic Implications. , 2015, Reproduction in domestic animals = Zuchthygiene.

[15]  Q. Lv,et al.  Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells. , 2015, International journal of clinical and experimental pathology.

[16]  A. Santos,et al.  Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours. Part 2: invasion, angiogenesis, metastasis and therapy. , 2015, Veterinary journal.

[17]  K. Ochiai,et al.  Reduced canine BRCA2 expression levels in mammary gland tumors , 2015, BMC Veterinary Research.

[18]  A. R. Fernandes,et al.  Characterization of antiproliferative potential and biological targets of a copper compound containing 4′-phenyl terpyridine , 2015, JBIC Journal of Biological Inorganic Chemistry.

[19]  Yaritza Salas,et al.  Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem , 2015, PloS one.

[20]  A. Børresen-Dale,et al.  Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN , 2015, PloS one.

[21]  F. Mattioli,et al.  In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors , 2015, BMC Cancer.

[22]  L. Bongiovanni,et al.  Survivin and Related Proteins in Canine Mammary Tumors , 2015, Veterinary pathology.

[23]  T. Motyl,et al.  Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling. , 2015, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[24]  P. Baptista,et al.  Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles , 2014, Expert review of molecular diagnostics.

[25]  M. Katoh.  Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases , 2014, Front. Cell Dev. Biol..

[26]  Chung-Tien Lin,et al.  Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines , 2014, BMC Veterinary Research.

[27]  M. Sherman,et al.  Pilot study of p62 DNA vaccine in dogs with mammary tumors , 2014, Oncotarget.

[28]  Derrick J. Morton,et al.  Snail Promotes Epithelial Mesenchymal Transition in Breast Cancer Cells in Part via Activation of Nuclear ERK2 , 2014, PloS one.

[29]  F. Queiroga,et al.  Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours , 2014, Veterinary Record.

[30]  J. Conde,et al.  Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis , 2014, Nanotoxicology.

[31]  Pedro V. Baptista,et al.  Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine , 2014, Front. Chem..

[32]  A. Martín-Ruiz,et al.  Immunohistochemical Vascular Factor Expression in Canine Inflammatory Mammary Carcinoma , 2014, Veterinary pathology.

[33]  Nagesha A S Rao,et al.  Ligand-Independent Canonical Wnt Activity in Canine Mammary Tumor Cell Lines Associated with Aberrant LEF1 Expression , 2014, PloS one.

[34]  J. Sur,et al.  Analysis of a New Histological and Molecular-Based Classification of Canine Mammary Neoplasia , 2014, Veterinary pathology.

[35]  W. Hanneman,et al.  Significance of ERα, HER2, and CAV1 expression and molecular subtype classification to canine mammary gland tumor , 2014, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[36]  R. Klopfleisch,et al.  Malignancy Associated MicroRNA Expression Changes in Canine Mammary Cancer of Different Malignancies , 2014, ISRN veterinary science.

[37]  I. Kirsan',et al.  Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours , 2014, Veterinary Research Communications.

[38]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[39]  S. Guil-Luna,et al.  The antiprogestins mifepristone and onapristone reduce cell proliferation in the canine mammary carcinoma cell line CMT-U27. , 2014, Histology and histopathology.

[40]  C. Benazzi,et al.  Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats. , 2014, Journal of comparative pathology.

[41]  A. Díaz-López,et al.  A core microRNA signature associated with inducers of the epithelial‐to‐mesenchymal transition , 2014, The Journal of pathology.

[42]  A. R. Fernandes,et al.  Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies , 2014, JBIC Journal of Biological Inorganic Chemistry.

[43]  T. Motyl,et al.  Macrophages Mediate a Switch between Canonical and Non-Canonical Wnt Pathways in Canine Mammary Tumors , 2014, PloS one.

[44]  C. Lopes,et al.  EGFR and microvessel density in canine malignant mammary tumours. , 2013, Research in veterinary science.

[45]  A. C. Alessi,et al.  Immunodetection of cells with a CD44+/CD24- phenotype in canine mammary neoplasms , 2013, BMC Veterinary Research.

[46]  T. Motyl,et al.  Migrastatin Analogues Inhibit Canine Mammary Cancer Cell Migration and Invasion , 2013, PloS one.

[47]  S. Hennecke,et al.  Genome Aberrations in Canine Mammary Carcinomas and Their Detection in Cell-Free Plasma DNA , 2013, PloS one.

[48]  Corbin E. Meacham,et al.  Tumour heterogeneity and cancer cell plasticity , 2013, Nature.

[49]  L. Pang,et al.  Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype. , 2013, Veterinary and comparative oncology.

[50]  Jenny G. Parvani,et al.  Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT , 2013, Breast Cancer Research.

[51]  A. R. Fernandes,et al.  Biological characterization of the antiproliferative potential of Co(II) and Sn(IV) coordination compounds in human cancer cell lines: a comparative proteomic approach , 2013, Drug metabolism and drug interactions.

[52]  A. R. Fernandes,et al.  Cobalt and Zinc Compounds Bearing 1,10-Phenanthroline-5,6-dione or 1,3,5-Triaza-7-phosphaadamantane Derivatives – Synthesis, Characterization, Cytotoxicity, and Cell Selectivity Studies , 2013 .

[53]  M. Pittet,et al.  MicroRNA-mediated control of macrophages and its implications for cancer. , 2013, Trends in immunology.

[54]  T. Motyl,et al.  Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells , 2013, BMC Veterinary Research.

[55]  Piotr J. Balwierz,et al.  Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. , 2013, Cancer cell.

[56]  J. Sur,et al.  Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers. , 2013, Journal of comparative pathology.

[57]  I. Dolka,et al.  Gene expression profiles in canine mammary carcinomas of various grades of malignancy , 2013, BMC Veterinary Research.

[58]  K. Lindblad-Toh,et al.  The ESR1 gene is associated with risk for canine mammary tumours , 2013, BMC Veterinary Research.

[59]  S. Caracappa,et al.  HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome. , 2013, Research in veterinary science.

[60]  João Conde,et al.  Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events. , 2013, Biomaterials.

[61]  J. Sur,et al.  Breed-related differences in altered BRCA1 expression, phenotype and subtype in malignant canine mammary tumors. , 2013, Veterinary journal.

[62]  T. Motyl,et al.  Expression of inflammation-mediated cluster of genes as a new marker of canine mammary malignancy , 2013, Veterinary Research Communications.

[63]  J. Dobson.  Breed-Predispositions to Cancer in Pedigree Dogs , 2013, ISRN veterinary science.

[64]  C. Perou,et al.  Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  M. He,et al.  MiR-124 targets Slug to regulate epithelial–mesenchymal transition and metastasis of breast cancer , 2012, Carcinogenesis.

[66]  A. Egenvall,et al.  Breed variations in the incidence of pyometra and mammary tumours in Swedish dogs. , 2012, Reproduction in domestic animals = Zuchthygiene.

[67]  F. Kopp,et al.  miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression , 2012, PloS one.

[68]  C. Benazzi,et al.  Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments? , 2012, BMC Veterinary Research.

[69]  K. Ochiai,et al.  Effects of the Missense Mutations in Canine BRCA2 on BRC Repeat 3 Functions and Comparative Analyses between Canine and Human BRC Repeat 3 , 2012, PloS one.

[70]  A. R. Fernandes,et al.  Cobalt complexes bearing scorpionate ligands: synthesis, characterization, cytotoxicity and DNA cleavage. , 2012, Dalton transactions.

[71]  D. Carter,et al.  Histologic, Immunohistochemical, and Clinical Features of 27 Mammary Tumors in 18 Male Dogs , 2012, Veterinary pathology.

[72]  M. Martinka,et al.  Sox4 Mediated Dicer Expression is Critical for Suppression of Melanoma Cell Invasion , 2012, Oncogene.

[73]  J. Conde,et al.  Gold-nanobeacons for real-time monitoring of RNA synthesis. , 2012, Biosensors & bioelectronics.

[74]  T. Huang,et al.  Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development , 2012, Breast Cancer Research.

[75]  G. Cassali,et al.  Canine malignant mammary gland neoplasms with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors. , 2012, In vivo.

[76]  I. Dolka,et al.  The gene expression profiles of canine mammary cancer cells grown with carcinoma-associated fibroblasts (CAFs) as a co-culture in vitro , 2012, BMC Veterinary Research.

[77]  T. Motyl,et al.  Growth hormone receptor (GHR) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line. , 2012, Veterinary and comparative oncology.

[78]  C. Van Ginneken,et al.  Canine mammary tumours, an overview. , 2011, Reproduction in domestic animals = Zuchthygiene.

[79]  A. Børresen-Dale,et al.  Identification of genetic variation in 11 candidate genes of canine mammary tumour. , 2011, Veterinary and comparative oncology.

[80]  M. Esteller.  Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[81]  F. Yu,et al.  miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro , 2011, Chinese journal of cancer.

[82]  R. Klopfleisch,et al.  The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas. , 2011, Veterinary journal.

[83]  T. Nakagawa,et al.  Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines. , 2011, Research in veterinary science.

[84]  R. Klopfleisch,et al.  Is there a malignant progression associated with a linear change in protein expression levels from normal canine mammary gland to metastatic mammary tumors? , 2011, Journal of proteome research.

[85]  J. Sur,et al.  Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study. , 2011, Veterinary journal.

[86]  Ê. Ferreira,et al.  Canine mammary mixed tumours: immunohistochemical expressions of EGFR and HER-2. , 2011, Australian veterinary journal.

[87]  C. Lopes,et al.  COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer. , 2011, Veterinary journal.

[88]  F. Queiroga,et al.  Canine mammary tumours as a model to study human breast cancer: most recent findings. , 2011, In vivo.

[89]  F. Guscetti,et al.  Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas. , 2011, Journal of veterinary internal medicine.

[90]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[91]  V. Zappulli,et al.  Development, Anatomy, Histology, Lymphatic Drainage, Clinical Features, and Cell Differentiation Markers of Canine Mammary Gland Neoplasms , 2011, Veterinary pathology.

[92]  V. Zappulli,et al.  Classification and Grading of Canine Mammary Tumors , 2011, Veterinary pathology.

[93]  R. Klopfleisch,et al.  Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer. , 2010, Veterinary and comparative oncology.

[94]  C. Lopes,et al.  Serum and intratumoural GH and IGF-I concentrations: prognostic factors in the outcome of canine mammary cancer. , 2010, Research in veterinary science.

[95]  R. Klopfleisch,et al.  Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles , 2010, BMC Cancer.

[96]  R. Klopfleisch,et al.  Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer. , 2010, Journal of proteome research.

[97]  Chi-Hung Huang,et al.  Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition , 2010, Nature Cell Biology.

[98]  J. Settleman,et al.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.

[99]  F. Ferrari,et al.  A MicroRNA Targeting Dicer for Metastasis Control , 2010, Cell.

[100]  Guanghai Yang,et al.  MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). , 2010, Clinica chimica acta; international journal of clinical chemistry.

[101]  C. Lopes,et al.  The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours. , 2010, Research in veterinary science.

[102]  W. Hsu,et al.  Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue. , 2010, Veterinary journal.

[103]  R. Klopfleisch,et al.  The Combined Expression Pattern of BMP2, LTBP4, and DERL1 Discriminates Malignant From Benign Canine Mammary Tumors , 2010, Veterinary pathology.

[104]  Chung-Tien Lin,et al.  Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines. , 2010, Research in veterinary science.

[105]  R. Klopfleisch,et al.  Loss of p27 expression in canine mammary tumors and their metastases. , 2010, Research in veterinary science.

[106]  G. Castellani,et al.  Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry , 2010, BMC veterinary research.

[107]  L. Peña,et al.  Histological, Immunohistological, and Ultrastructural Description of Vasculogenic Mimicry in Canine Mammary Cancer , 2009, Veterinary pathology.

[108]  F. Schmitt,et al.  Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues. , 2009, Research in veterinary science.

[109]  K. Lindblad-Toh,et al.  Mammary tumor development in dogs is associated with BRCA1 and BRCA2. , 2009, Cancer research.

[110]  F. Mutinelli,et al.  Animal tumour registry of two provinces in northern Italy: incidence of spontaneous tumours in dogs and cats , 2009, BMC veterinary research.

[111]  F. Shofer,et al.  Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. , 2009, Veterinary and comparative oncology.

[112]  Chao-Chin Chang,et al.  Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors. , 2009, Journal of the American Veterinary Medical Association.

[113]  N. Voirin,et al.  Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype , 2009, British Journal of Cancer.

[114]  R. Klopfleisch,et al.  Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands. , 2009, Research in veterinary science.

[115]  L. Peña,et al.  Survival time of dogs with inflammatory mammary cancer treated with palliative therapy alone or palliative therapy plus chemotherapy , 2009, Veterinary Record.

[116]  Markus Munz,et al.  The emerging role of EpCAM in cancer and stem cell signaling. , 2009, Cancer research.

[117]  H. Schoon,et al.  Expression of ABC-transport proteins in canine mammary cancer: consequences for chemotherapy. , 2009, Reproduction in domestic animals = Zuchthygiene.

[118]  F. Millanta,et al.  Reduced PTEN Protein Expression and Its Prognostic Implications in Canine and Feline Mammary Tumors , 2009, Veterinary pathology.

[119]  F. Queiroga,et al.  Positive correlation of steroid hormones and EGF in canine mammary cancer , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[120]  R. Klopfleisch,et al.  Increased Expression of BRCA2 and RAD51 in Lymph Node Metastases of Canine Mammary Adenocarcinomas , 2009, Veterinary pathology.

[121]  K. Tobias,et al.  Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. , 2009, The Canadian veterinary journal = La revue veterinaire canadienne.

[122]  R. Medeiros,et al.  COX-2 expression in canine normal and neoplastic mammary gland. , 2009, Journal of comparative pathology.

[123]  W. Hsu,et al.  Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene. , 2009, Veterinary journal.

[124]  J. Castle,et al.  Comparative expression pathway analysis of human and canine mammary tumors , 2009, BMC Genomics.

[125]  M. Dean.  ABC Transporters, Drug Resistance, and Cancer Stem Cells , 2009, Journal of Mammary Gland Biology and Neoplasia.

[126]  P. DeInnocentes,et al.  Phenotype‐rescue of cyclin‐dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer , 2009, Journal of cellular biochemistry.

[127]  V. Kim,et al.  Biogenesis of small RNAs in animals , 2009, Nature Reviews Molecular Cell Biology.

[128]  Domenico Coppola,et al.  MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer* , 2008, Journal of Biological Chemistry.

[129]  Tyler E. Miller,et al.  MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1*♦ , 2008, Journal of Biological Chemistry.

[130]  C. Qiu,et al.  Expression and significance of PTEN in canine mammary gland tumours. , 2008, Research in veterinary science.

[131]  D. Gomez,et al.  Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: a pilot study. , 2008, Veterinary journal.

[132]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[133]  F. Schmitt,et al.  Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification , 2008, Virchows Archiv.

[134]  M. Stickney,et al.  MicroRNA expression in canine mammary cancer , 2008, Mammalian Genome.

[135]  M. Ceppi,et al.  Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa, Italy. , 2008, Journal of veterinary internal medicine.

[136]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[137]  L. Marconato,et al.  Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs. , 2008, Veterinary and comparative oncology.

[138]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[139]  T. Brabletz,et al.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells , 2008, EMBO reports.

[140]  F. Queiroga,et al.  Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17β-estradiol) in canine mammary tumours , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[141]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[142]  Gema Moreno-Bueno,et al.  Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.

[143]  M. Paoloni,et al.  Translation of new cancer treatments from pet dogs to humans , 2008, Nature Reviews Cancer.

[144]  A. Wehrend,et al.  Mammary tumor recurrence in bitches after regional mastectomy. , 2008, Veterinary surgery : VS.

[145]  Louise R Howe,et al.  Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer , 2007, Breast Cancer Research.

[146]  B. Davidson,et al.  RNA polymerase III transcribes human microRNAs , 2006, Nature Structural &Molecular Biology.

[147]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[148]  W. Baumgärtner,et al.  Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel. , 2006, Journal of veterinary internal medicine.

[149]  Byoung-Tak Zhang,et al.  Molecular Basis for the Recognition of Primary microRNAs by the Drosha-DGCR8 Complex , 2006, Cell.

[150]  T. Sørlie,et al.  Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms , 2006, BMC Genomics.

[151]  D. Karunagaran,et al.  Of humans and canines: a comparative evaluation of heat shock and apoptosis-associated proteins in mammary tumors. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[152]  V. Kim,et al.  The role of PACT in the RNA silencing pathway , 2006, The EMBO journal.

[153]  K Shimada,et al.  FADD phosphorylation is critical for cell cycle regulation in breast cancer cells , 2006, British Journal of Cancer.

[154]  Z. Mourelatos,et al.  A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. , 2005, Genes & development.

[155]  F. Millanta,et al.  Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. , 2005, Research in veterinary science.

[156]  Chao-Chin Chang,et al.  Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002). , 2005, Journal of the American Veterinary Medical Association.

[157]  T. Constantinidis,et al.  Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. , 2005, Journal of comparative pathology.

[158]  Anne Gatignol,et al.  TRBP, a regulator of cellular PKR and HIV‐1 virus expression, interacts with Dicer and functions in RNA silencing , 2005, EMBO reports.

[159]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[160]  R. Shiekhattar,et al.  TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing , 2005, Nature.

[161]  B. Cullen,et al.  Efficient Processing of Primary microRNA Hairpins by Drosha Requires Flanking Nonstructured RNA Sequences* , 2005, Journal of Biological Chemistry.

[162]  K. Uchida,et al.  Clinicopathological survey of 101 canine mammary gland tumors: differences between small-breed dogs and others. , 2005, The Journal of veterinary medical science.

[163]  Y. Millán,et al.  A Prospective Analysis of Immunohistochemically Determined Estrogen Receptor α and Progesterone Receptor Expression and Host and Tumor Factors as Predictors of Disease-free Period in Mammary Tumors of the Dog , 2005, Veterinary pathology.

[164]  F. Queiroga,et al.  Role of steroid hormones and prolactin in canine mammary cancer , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[165]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[166]  V. Kim,et al.  The Drosha-DGCR8 complex in primary microRNA processing. , 2004, Genes & development.

[167]  B. Cullen,et al.  Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. , 2004, RNA.

[168]  G. Hannon,et al.  Processing of primary microRNAs by the Microprocessor complex , 2004, Nature.

[169]  F. Schmitt,et al.  c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[170]  Sanghyuk Lee,et al.  MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.

[171]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[172]  H. Moses,et al.  Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. , 2004, Neoplasia.

[173]  Y. Yarden,et al.  Oncogenic growth factor receptors: implications for signal transduction therapy. , 2004, Seminars in cancer biology.

[174]  Chung-Ho Lee,et al.  Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. , 2004, Journal of veterinary science.

[175]  A. Hershey,et al.  Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors. , 2004, Journal of veterinary internal medicine.

[176]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[177]  V. Kim,et al.  The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.

[178]  S. Ramón y. Cajal,et al.  Oncogene HER-2 in Canine Mammary Gland Carcinomas , 2003, Breast Cancer Research and Treatment.

[179]  N. Shenoy,et al.  Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[180]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[181]  L. Peña,et al.  BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables. , 2003, Journal of comparative pathology.

[182]  L. Peña,et al.  Canine Inflammatory Mammary Carcinoma: Histopathology, Immunohistochemistry and Clinical Implications of 21 Cases , 2003, Breast Cancer Research and Treatment.

[183]  J. Sirois,et al.  Cyclooxygenase-2 Expression in Canine Mammary Tumors , 2003, Veterinary pathology.

[184]  Eduard Batlle,et al.  Snail Induction of Epithelial to Mesenchymal Transition in Tumor Cells Is Accompanied by MUC1 Repression andZEB1 Expression* , 2002, The Journal of Biological Chemistry.

[185]  G. De Vico,et al.  Expression of Vascular Endothelial Growth Factor in Canine Mammary Tumors , 2002, Veterinary pathology.

[186]  J. Wood,et al.  Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. , 2002, The Journal of small animal practice.

[187]  S. Bustin,et al.  The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. , 2002, Current medical research and opinion.

[188]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[189]  M. Maeda,et al.  Overexpression of the p53 gene product in canine mammary tumors. , 2001, Oncology reports.

[190]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[191]  A. Pasquinelli,et al.  Genes and Mechanisms Related to RNA Interference Regulate Expression of the Small Temporal RNAs that Control C. elegans Developmental Timing , 2001, Cell.

[192]  A. Pasquinelli,et al.  A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA , 2001, Science.

[193]  T. Constantinidis,et al.  Adjuvant post-operative chemotherapy in bitches with mammary cancer. , 2001, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.

[194]  A. Caudy,et al.  Role for a bidentate ribonuclease in the initiation step of RNA interference , 2001 .

[195]  G. Rutteman,et al.  Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[196]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[197]  H. Takahashi,et al.  p53 Gene Mutations Occurring in Spontaneous Benign and Malignant Mammary Tumors of the Dog , 2000, Veterinary pathology.

[198]  A. C. Lee,et al.  Classification and Behavior of Canine Mammary Epithelial Neoplasms Based on Life-span Observations in Beagles , 1999, Veterinary pathology.

[199]  Nazneen,et al.  Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. , 1999, Journal of the National Cancer Institute.

[200]  Toshiharu Hayashi,et al.  Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. , 1999, The Journal of veterinary medical science.

[201]  J. Pelletier,et al.  Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia , 1998, Breast Cancer Research and Treatment.

[202]  A. Beynen,et al.  Relation between habitual diet and canine mammary tumors in a case-control study. , 1998, Journal of veterinary internal medicine.

[203]  Y. Yarden,et al.  The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactions , 1997, FEBS letters.

[204]  E. van Garderen,et al.  Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop. , 1997, The American journal of pathology.

[205]  C. Cornelisse,et al.  P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog. , 1996, Anticancer research.

[206]  G. Rutteman,et al.  New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: Induction of the local biosynthesis of growth hormone (GH) in the mammary gland of dogs, cats and humans , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[207]  E. van Garderen,et al.  Comparison of the histological changes in the dog after treatment with the progestins medroxyprogesterone acetate and proligestone. , 1995, The Veterinary quarterly.

[208]  G. Leclercq,et al.  Comparison of estrogen and progesterone receptor expression in normal and tumor mammary tissues from dogs. , 1995, American journal of veterinary research.

[209]  E. van Garderen,et al.  Growth hormone mRNA in mammary gland tumors of dogs and cats. , 1995, The Journal of clinical investigation.

[210]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[211]  G. Rutteman.  Contraceptive steroids and the mammary gland: Is there a hazard? , 1992, Breast Cancer Research and Treatment.

[212]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[213]  L. Glickman,et al.  Body conformation, diet, and risk of breast cancer in pet dogs: a case-control study. , 1991, American journal of epidemiology.

[214]  W. E. van den Brom,et al.  Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states. , 1988, British Journal of Cancer.

[215]  C. Cornelisse,et al.  Flow cytometric analysis of DNA ploidy in canine mammary tumors. , 1988, Cancer research.

[216]  A. Lindgren,et al.  Comparison of Histology and Clinical Variables to DNA Ploidy in Canine Mammary Tumors , 1988, Veterinary pathology.

[217]  T. Inaba,et al.  Estrogen and progesterone receptors and progesterone metabolism in canine mammary tumours. , 1984, Nihon juigaku zasshi. The Japanese journal of veterinary science.

[218]  M. Black,et al.  Canine Mammary Epithelial Neoplasms: Biologic Implications of Morphologic Characteristics Assessed in 232 Dogs , 1983, Veterinary pathology.

[219]  D. Meisel,et al.  Adsorption and surface-enhanced Raman of dyes on silver and gold sols , 1982 .

[220]  E. Macewen,et al.  Estrogen receptors in canine mammary tumors. , 1982, Cancer research.

[221]  H. W. Casey,et al.  Gross and histopathologic effects of medroxyprogesterone acetate and progesterone on the mammary glands of adult beagle bitches. , 1981, Fertility and sterility.

[222]  H. W. Casey,et al.  Malignant mammary tumors in beagle dogs dosed with investigational oral contraceptive steroids. , 1980, Journal of the National Cancer Institute.

[223]  H. W. Casey,et al.  Mammary nodules in beagle dogs administered investigational oral contraceptive steroids. , 1978, Journal of the National Cancer Institute.

[224]  G. Betton.  Agglutination reactions of spontaneous canine tumour cells, induced by concanavalin a, demonstrated by an isotopic assay , 1976, International journal of cancer.

[225]  D. Taylor,et al.  Factors influencing canine mammary cancer development and postsurgical survival. , 1969, Journal of the National Cancer Institute.

[226]  M. Klauber,et al.  Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. , 1968, Journal of the National Cancer Institute.

[227]  I Iu IUDIN,et al.  [Tumors of the mammary gland]. , 1955, Meditsinskaia sestra.

[228]  Wenyu Li,et al.  Protective Role of Selenium Compounds on the Proliferation, Apoptosis, and Angiogenesis of a Canine Breast Cancer Cell Line , 2015, Biological Trace Element Research.

[229]  K. Axhausen,et al.  The Swiss Canine Cancer Registry: a retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008. , 2015, Journal of comparative pathology.

[230]  C. Lopes,et al.  Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours. , 2014, Journal of comparative pathology.

[231]  Yue Wang,et al.  Epidermal growth factor promotes transforming growth factor-β1-induced epithelial-mesenchymal transition in HK-2 cells through a synergistic effect on Snail , 2013, Molecular Biology Reports.

[232]  D. Thamm,et al.  Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept study. , 2012, Veterinary journal.

[233]  Min Soo Bae,et al.  Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. , 2012, Biomaterials.

[234]  D. Gomez,et al.  Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade. , 2011, Journal of the American Animal Hospital Association.

[235]  Robin L. Jones,et al.  Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. , 2011, European journal of cancer.

[236]  M. Fischer,et al.  Amine coupling through EDC/NHS: a practical approach. , 2010, Methods in molecular biology.

[237]  F. Millanta,et al.  Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma. , 2010, Journal of comparative pathology.

[238]  B. Kitchell,et al.  Combined gemcitabine and carboplatin therapy for carcinomas in dogs. , 2009, Journal of veterinary internal medicine.

[239]  U. Langsenlehner,et al.  COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic for molecular markers , 2006, Breast Cancer Research and Treatment.

[240]  C.T. Lin,et al.  Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours. , 2006, Journal of comparative pathology.

[241]  A. Nečas,et al.  Breed and Age as Risk Factors for Canine Mammary Tumours , 2005 .

[242]  D. Dinev,et al.  Original Contribution EFFICACY AND TOXICITY OF DOXORUBICIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN DOGS WITH SPONTANEOUS MAMMARY TUMOURS , 2005 .

[243]  F. Shofer,et al.  Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. , 2000, Journal of veterinary internal medicine.

[244]  P. Lombardi,et al.  Ovarian function suppression with a GnRH analogue: D-ser(But[t])[6]-Arzgly[10]-LHRH (Goserelin) in hormone dependent canine mammary cancer. , 1999, Journal of veterinary pharmacology and therapeutics.

[245]  J. Milner,et al.  Identification of tumour-associated and germ line p53 mutations in canine mammary cancer , 1999 .

[246]  B. Mayr,et al.  Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs. , 1998, American journal of veterinary research.

[247]  J. V. van Neck,et al.  The role of progestins, insulin-like growth factor (IGF) and IGF-binding proteins in the normal and neoplastic mammary gland of the bitch: a review. , 1997, Journal of reproduction and fertility. Supplement.

[248]  E. van Garderen,et al.  Progestin-induced growth hormone excess in the dog originates in the mammary gland. , 1994, Endocrinology.

[249]  W. Misdorp.  Progestagens and mammary tumours in dogs and cats. , 1991, Acta endocrinologica.

[250]  W. Priester,et al.  The occurrence of tumors in domestic animals. , 1980, National Cancer Institute monograph.

[251]  R. Geil,et al.  FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey. , 1977, Journal of toxicology and environmental health.